Publications by authors named "Shamia Faison"

Claim this Profile
A
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Dordaviprone.
Shamia L Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion E Morrison

J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling.
Swati Jaiswal, Nikunjkumar K Patel, Hannah M Jones, Savannah McFeely, Shamia L Faison

CPT Pharmacometrics Syst Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, randomized, crossover trial to assess the effect of itraconazole on the pharmacokinetics of dordaviprone in healthy adults.
Shamia L Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion E Morrison

Br J Clin Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Severe Renal Impairment on Dordaviprone (ONC201) Pharmacokinetics.
Shamia L Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion E Morrison

Drugs R D· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study to Evaluate the Absorption, Metabolism, and Disposition of Dordaviprone in Healthy Adult Participants.
Yohannes Teffera, Tim Tippin, Angela Bartkus, Francine A de Castro, Shamia L Faison

Clin Pharmacol Drug Dev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult Subjects.
Shamia L Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion Morrison

Clin Pharmacol Drug Dev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co-Administration of the Proton-Pump Inhibitor Rabeprazole.
Shamia L Faison, Joelle Batonga, Thangam Arumugham, Angela Bartkus, Marion Morrison

J Clin Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Yazmin Odia, Carl Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Shamia L Faison

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Cytochrome P450 4F2 Genotyping to Assess Drug Interaction Risk for Brincidovovir, a Cytochrome P450 4F2 Substrate.
Tim Tippin, Shamia Faison, Virna Schuck, John Dunn, Odin Naderer

Clin Pharmacol Drug Dev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults.
Shamia L Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Zhao Wang

J Clin Psychopharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults.
Shamia L Faison, Nicholas Fry, Toyin Adewole, Oyinkansola Odebo, Stefan Schwabe

Clin Drug Investig· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults.
Azmi Nasser, Shamia L Faison, Tesfaye Liranso, Toyin Adewole, Gregory D Busse

J Clin Psychiatry· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation.
Shamia Faison, Roberto Gomeni, Shannon Mendes, Welton O'Neal, Stefan Schwabe

Clin Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.
Shamia L Faison, Charles W Schindler, Steven R Goldberg, Jia Bei Wang

BMC Pharmacol Toxicol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis